In addition, nanoparticles are excellent candidates for LDL encapsulating, penetrating, and transporting anticancer agents to cancer tumors and tissues due to their small size and binding affinity to LDL-receptor (Alhadad et al., 2020; Jaragh Alhadad, 2021). The gene discussed is LDLR; the disease is cancer.